Human data.
Human models.
Human healing.
WHY WE EXIST
Ochre exists to end the need for liver transplants.
1.5m people globally die of liver disease. For the vast majority of these, the only curative treatment option is a liver transplant. With just over 40,000 transplants done globally annually. This is a medical lottery, not medicine. This is what Ochre exists to change.
European Health for All database. Data missing in 2000.
“Liver disease is the third leading cause of premature death.” UK Health Security Agency, July 2021
HOW WE DO THINGS DIFFERENTLY
Human Discovery Platform
We’ve invested over $20m to build the most comprehensive human liver data sets. By integrating gene perturbation atlases with patient disease atlases, we make causal predictions about new drug targets.
Human Validation Platform
By combining AI with human validation models such as perfused livers, diseased tissue slices and primary cells, we model biological complexity at scale.
RNA Platform
We make our own RNA therapies in house, reducing R&D cycle times from years to weeks.
WHO WE ARE
Built on decades of leading genomics, AI, drug discovery and development experience, Ochre Bio’s teams are our secret sauce built on a foundation of ambitious science.
Robert Mart
Sachin Patil
Michal Matuszewski
Fleur Palmer-Paquis
Calum Irwin
Nick Taylor
Scientist
Lab Manager
Clinical Research Scientist
Research Associate
